WATCH NOW


    
 

John Vandermosten: Biotech Idea MRK

At MoneyShow, John Vandermosten of Zacks Investment Research: one area big in cancer drugs has been checkpoint inhibitors, like Keytruda from Merck. They work well in about 20% of people.
John Vandermosten
Duration: 7:49